The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 12, 2016

Filed:

May. 29, 2012
Applicants:

Mark John Berry, Sharnbrook, GB;

Mark Ian Fowler, Sharnbrook, GB;

Alan David Heath, Sharnbrook, GB;

Inventors:

Mark John Berry, Sharnbrook, GB;

Mark Ian Fowler, Sharnbrook, GB;

Alan David Heath, Sharnbrook, GB;

Assignee:

Conopco, Inc., Englewood Cliffs, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7034 (2006.01); A61K 31/7048 (2006.01); A23L 1/30 (2006.01); A61K 31/352 (2006.01); A61K 31/715 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7048 (2013.01); A23L 1/3002 (2013.01); A61K 31/352 (2013.01); A61K 31/7034 (2013.01); A61K 31/715 (2013.01); A23V 2002/00 (2013.01);
Abstract

Foods or meals high in available carbohydrate such as sucrose or starch increase post-prandial blood glucose concentrations. Repeated high post-prandial plasma glucose 'spikes' are associated with an increased risk of developing type II diabetes. Unregulated glycemic excursions are undesirable, and any reduction or 'blunting' of the post-prandial glucose concentration in blood is potentially beneficial. This invention relates to an edible composition for delay of intestinal glucose uptake through synergistic inhibition of both active sodium glucose co-transporter 1 (SGLT1) and passive glucose transporter 2 (GLUT2) leading to flattening or blunting of the post-prandial glucose peak. Thus in a first aspect of the invention, an edible composition is provided, the composition comprising at least 5% dry weight at least one flavonoid aglycone and at least 5% dry weight at least one flavonoid glucoside, wherein the flavonoid glucoside is at least 20%, preferably at least 40%, most preferably at least 60% more resistant to hydrolysis by lactase phloridzin hydrolase than quercetin-4-glucoside, and wherein the flavonoid aglycone is a GLUT 2 inhibitor and the flavonoid glucoside is a SGLT 1 inhibitor.


Find Patent Forward Citations

Loading…